- $1.21bn
- $2.81bn
- $3.27bn
- 81
- 48
- 90
- 85
Annual income statement for Pitney Bowes, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,205 | 3,554 | 3,674 | 3,538 | 3,266 |
Cost of Revenue | |||||
Gross Profit | 1,283 | 1,149 | 1,122 | 1,080 | 1,022 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3,067 | 3,632 | 3,584 | 3,423 | 3,572 |
Operating Profit | 138 | -77.6 | 89.5 | 115 | -306 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 26.7 | -183 | -7.42 | 39.9 | -407 |
Provision for Income Taxes | |||||
Net Income After Taxes | 39.9 | -190 | 3.51 | 36.9 | -386 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 194 | -180 | -1.35 | 36.9 | -386 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 194 | -180 | -1.35 | 36.9 | -386 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.48 | -0.281 | 0.091 | 0.193 | -0.724 |
Dividends per Share |